Postbooster Antibodies from Humans as Source of Diphtheria Antitoxin

被引：4
作者：
Bermejo-Martin, Jesus F. [1 ]
Avila-Alonso, Ana [1 ]
Gonzalez-Rivera, Milagros [2 ]
Tamayo, Eduardo [1 ]
Maria Eiros, Jose [1 ]
Almansa, Raquel [1 ]
机构：
[1] Hosp Clin Univ Valladolid, Valladolid 47005, Spain
[2] Hosp Gen Univ Gregorio Maranon, Madrid, Spain
来源：
EMERGING INFECTIOUS DISEASES | 2016年 / 22卷 / 07期
关键词：
ACELLULAR PERTUSSIS-VACCINE; BOOSTER VACCINATION; TETANUS TOXOIDS; YOUNG-ADULTS; IMMUNOGENICITY; SAFETY; TRIAL;
D O I：
10.3201/eid2207.151670
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Diphtheria antitoxin for therapeutic use is in limited supply. A potential source might be affinity-purified antibodies originally derived from plasma of adults who received a booster dose of a vaccine containing diphtheria toxoid. These antibodies might be useful for treating even severe cases of diphtheria.
引用
收藏
页码：1265 / 1267
页数：3
相关论文
共 15 条
  • [1] Evaluation of diphtheria convalescent patients to serve as donors for the production of anti-diphtheria immunoglobulin preparations
    Bissumbhar, B
    Rakhmanova, AG
    Berbers, GAM
    Iakolev, A
    Nosikova, E
    Melnick, O
    Ovtcharenko, E
    Rümke, HC
    Ruitenberg, EJ
    [J]. VACCINE, 2004, 22 (15-16) : 1886 - 1891
  • [2] Immunogenicity and safety of a tetanus toxoid, reduced diphtheria toxoid and three-component acellular pertussis vaccine in adults 19-64 years of age
    Blatter, Mark
    Friedland, Leonard R.
    Weston, Wayde M.
    Li, Ping
    Howe, Barbara
    [J]. VACCINE, 2009, 27 (05) : 765 - 772
  • [3] Access to diphtheria antitoxin for therapy and diagnostics
    Both, L.
    White, J.
    Mandal, S.
    Efstratiou, A.
    [J]. EUROSURVEILLANCE, 2014, 19 (24): : 19 - 24
  • [4] Centers for Disease Control and Prevention, USE OF DIPHTHERIA AN
  • [5] Affinity-puritied human immunoglobulin G that binds a lacto-N-neotetraose-dependent lipooligosaccharide structure is bactericidal for serogroup B Neisseria meningitidis
    Estabrook, Michele M.
    Jarvis, Gary A.
    Griffiss, J. McLeod
    [J]. INFECTION AND IMMUNITY, 2007, 75 (02) : 1025 - 1033
  • [6] European Centre for Disease Prevention and Control, RAP RISK ASS CAS DIP
  • [7] Tolerability and antibody response in adolescents and adults revaccinated with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine adsorbed (Tdap) 4-5 years after a previous dose
    Halperin, Scott A.
    McNeil, Shelly
    Langley, Joanne
    Blatter, Mark
    Dionne, Marc
    Embree, Joanne
    Johnson, Roehl
    Latiolais, Thomas
    Meekison, William
    Noya, Francisco
    Senders, Shelly
    Zickler, Paul
    Johnson, David R.
    [J]. VACCINE, 2011, 29 (46) : 8459 - 8465
  • [8] Immunogenicity and Safety after Booster Vaccination of Diphtheria, Tetanus, and Acellular Pertussis in Young Adults: an Open Randomized Controlled Trial in Japan
    Hara, Megumi
    Okada, Kenji
    Yamaguchi, Yuko
    Uno, Shingo
    Otsuka, Yasuko
    Shimanoe, Chisato
    Nanri, Hinako
    Horita, Mikako
    Ozaki, Iwata
    Nishida, Yuichiro
    Tanaka, Keitaro
    [J]. CLINICAL AND VACCINE IMMUNOLOGY, 2013, 20 (12) : 1799 - 1804
  • [9] Booster vaccination in the elderly:: Their success depends on the vaccine type applied earlier in life as well as on pre-vaccination antibody titers
    Kaml, Maria
    Weiskirchner, Ilka
    Keller, Michael
    Luft, Thomas
    Hoster, Eva
    Hasford, Joerg
    Young, Linda
    Bartlett, Bill
    Neuner, Christoph
    Fischer, Karl-Heinz
    Neuman, Ber
    Wuerzner, Reinhard
    Grubeck-Loebenstein, Beatrix
    [J]. VACCINE, 2006, 24 (47-48) : 6808 - 6811
  • [10] Decennial Administration of a Reduced Antigen Content Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine in Young Adults
    Mertsola, Jussi
    Van Der Meeren, Olivier
    He, Qiushui
    Linko-Parvinen, Anna
    Ramakrishnan, Gunasekaran
    Mannermaa, Leni
    Soila, Maaria
    Pulkkinen, Markku
    Jacquet, Jeanne-Marie
    [J]. CLINICAL INFECTIOUS DISEASES, 2010, 51 (06) : 656 - 662
12